Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet
Increased Testing Demand
ABBOTT PARK, Illinois, April 16, 2013
ABBOTT PARK, Illinois, April 16, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today
announced the global launch of the ACCELERATOR® a 3600, a next generation
automation solution, to help laboratories address the need to process tests
faster while handling increased volume. Advances in technology and automation
within the lab have led to more timely results leading to improved patient
care. Automation systems include the various instruments, devices, and
software algorithms used in laboratories.
"As laboratories around the world face challenges due to staffing shortages,
budget constraints, and increased demands, advances in automation technology
such as Abbott's ACCELERATOR a3600 can help labs be more efficient and
productive," said Brian Blaser, executive vice president, Diagnostics
Products, Abbott. "Labs using automation can achieve more than 40 percent
greater efficiency, helping them adapt to meet current and future demand,
which is particularly important as approximately 70 percent of medical
decisions are informed by diagnostic testing." [1,2]
The ACCELERATOR a 3600 is a laboratory automation track system that can
process up to 3,600 samples per hour and handle multiple tube sizes and types
simultaneously. By automating routine, manual tasks, this system may help labs
reduce error and improve efficiency. Another advantage of the system is a
modular design that offers labs the ability to install up to 99 combined
analyzers and modules on a single system, which means that labs can address
their testing needs today while planning for the future.
The ACCELERATOR a 3600 automation solution, developed with Abbott partner
Swiss-based Inpeco SA, is available worldwide pending country registration. To
learn more about the role diagnostics can play in increasing quality and
efficiency in labs, please click here .
The ACCELERATOR a 3600 is a modular system designed to automate pre-analytical
and post-analytical processing, sample-handling, and processing in the
laboratory. The system consolidates multiple analytical instruments into a
unified workstation by employing a common sample processing capability.
Through communication connections among the automation system, analyzers, and
the laboratory information system (LIS) or middleware, the automation software
provides workload and sample-order management, as well as instrument
operational status monitoring.
For complete information, see the product information at
About Abbott Diagnostics
Abbott is a global leader in in vitro diagnostics and offers a broad range of
innovative instrument systems and tests for hospitals, reference labs,
molecular labs, blood banks, physician offices and clinics. With more than
22,000 customers in more than 100 countries, Abbott's diagnostic products
offer customers automation, convenience, bedside testing, cost-effectiveness,
and flexibility. Abbott has helped transform the practice of medical diagnosis
from an art to a science through the company's commitment to improving patient
care and lowering costs.
Abbott is a global healthcare company devoted to improving life through the
development of products and technologies that span the breadth of healthcare.
With a portfolio of leading, science-based offerings in diagnostics, medical
devices, nutritionals and branded generic pharmaceuticals, Abbott serves
people in more than 150 countries and employs approximately 70,000 people.
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.
 ^ Rajkovich, D, Mercer, W. The Impact of Automation on Laboratory
Operations. CHI Solutions 2009; 1-3.
 Diagnostics and Policy: Innovation and Value. AdvaMedDX.org. Accessed
March 7, 2013.
Contact: Media, Darcy Ross, (847) 937-3655, or Jessica Masuga, (847) 935-0650;
or Financial, Tina Ventura, (847) 935-9390
Press spacebar to pause and continue. Press esc to stop.